6th Edition of World Obesity and Weight Management Congress
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Edition of World Obesity and Weight Management Congress — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
6th Edition of World Obesity and Weight Management Congress
Event Dates: October 19-21, 2026
Venue: Hilton Boston/Woburn, 2 Forbes Road, Woburn, Massachusetts, 01801, USA
Event Type: Hybrid (In-person and Virtual)
Event Description
The 6th Edition of World Obesity and Weight Management Congress (WOC 2026) is a premier global event dedicated to advancing research, innovation, and practical strategies in the field of obesity and weight management. Organized by Magnus Group, this conference will take place from October 19 to 21, 2026, at the Hilton Boston/Woburn in Woburn, Massachusetts, USA, and will also be accessible virtually to a global audience. The event is themed "Global Perspectives on Obesity: Innovation to Impact", aiming to bring together healthcare professionals, nutritionists, endocrinologists, researchers, policymakers, and industry leaders to connect, exchange ideas, and foster collaborations.
Who Attends (Buyers / Attendees)
- Healthcare professionals specializing in obesity and weight management
- Nutritionists and dietitians
- Endocrinologists and metabolic disease specialists
- Researchers and academics in obesity and related fields
- Policymakers involved in public health and wellness initiatives
- Industry leaders and representatives from pharmaceutical, medical device, and wellness companies
- Students and emerging researchers in healthcare and related disciplines
Location and Geographic Reach
Location: Hilton Boston/Woburn, Woburn, Massachusetts, USA
Geographic Reach: Global, with a hybrid format allowing both in-person attendance in the USA and virtual participation from around the world.
Audience Reach
The event has a global audience reach, attracting attendees from various countries. The hybrid format enhances accessibility, allowing professionals worldwide to engage with the conference content.
Sample Buyer Company Names and Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Novartis Pharmaceuticals Corp | https://www.novartis.com | Director of Obesity Research / Product Manager, Obesity Therapeutics | Global pharmaceutical company with interests in metabolic disorders and obesity treatments. |
| 2 | Johnson & Johnson Health Tech | https://www.jnj.com | Business Development Manager, Digital Health / Obesity Solutions Lead | Involved in digital health innovations, including apps and technologies for weight management. |
| 3 | Abbott Nutrition | https://www.abbott.com/nutrition | Director of Clinical Nutrition / Obesity Program Manager | Major player in nutritional sciences, offering products and solutions for weight management. |
| 4 | Brunswick Corporation (Life Fitness) | https://www.brunswick.com | Product Manager, Fitness Equipment / Wellness Program Director | Manufacturer of fitness equipment, relevant for physical activity and exercise therapy in obesity management. |
| 5 | Google Health | https://health.google/ | Director of Digital Health Initiatives / AI in Healthcare Lead | Engaged in AI and digital solutions for health management, including obesity and lifestyle diseases. |
| 6 | GlaxoSmithKline (GSK) | https://www.gsk.com | Medical Science Liaison, Obesity / Director, Metabolic Health | Pharmaceutical company with a focus on respiratory and metabolic diseases, including obesity-related conditions. |
| 7 | Oracle Health Sciences | https://www.oracle.com/health-sciences | VP, Health Data Analytics / Director, Clinical Research Technology | Provides data management solutions for clinical research, relevant for obesity studies and trials. |
| 8 | Fitbit (a Google company) | https://www.fitbit.com | Product Manager, Health and Fitness Devices / Digital Health Strategist | Developer of wearable fitness trackers, relevant for monitoring physical activity and weight management. |
| 9 | Mindbody | https://www.mindbodyonline.com | Director of Wellness Programs / Business Development, Health and Wellness | Platform for wellness and fitness services, connecting users with weight management and fitness programs. |
| 10 | Cleveland Clinic | https://www.clevelandclinic.org | Director of Bariatric Services / Chief, Obesity Medicine | Prominent healthcare institution with specialized departments in obesity and bariatric care. |
| 11 | Mayo Clinic | https://www.mayoclinic.org | Chair, Obesity Medicine / Director, Weight Management Programs | Leading medical center with comprehensive weight management and obesity treatment programs. |
| 12 | Pfizer Inc. | https://www.pfizer.com | Director, Metabolic Disorders / Obesity Therapeutics Lead | Global pharmaceutical company researching and developing treatments for obesity and related metabolic disorders. |
| 13 | Healthline Media | https://www.healthline.com | Director of Health Content / Digital Health Marketing Lead | Health information and media company, providing content and resources on obesity and weight management for the public. |
| 14 | MyFitnessPal (a Dotdash Meredith brand) | https://www.myfitnesspal.com | Product Manager, Digital Weight Management Tools / Marketing Director, Health and Wellness | Provider of digital platforms for tracking diet and exercise, widely used for weight management. |
| 15 | Obesity Medicine Association (OMA) | https://www.obesitymed.org | Executive Director / President, Obesity Medicine Association | Professional organization for healthcare providers specializing in obesity medicine, offering education and certification. |
Job Profiles, Industries, and Event Type
Best Job Profiles to Target:
- Director of Obesity Research
- Product Manager, Obesity Therapeutics
- Business Development Manager, Digital Health
- Director of Clinical Nutrition
- Medical Science Liaison, Obesity
- Director, Metabolic Health
- VP, Health Data Analytics
- Product Manager, Health and Fitness Devices
- Director of Bariatric Services
- Chief, Obesity Medicine
Industries:
- Healthcare & Medical Devices
- Pharmaceuticals
- Nutrition & Wellness
- Digital Health & AI
- Fitness & Exercise Technology
- Health Information & Media
- Professional Associations
Event Type: Medical & Scientific Conference, Hybrid Format
Estimated Attendance
The conference is expected to attract a diverse audience, with estimated attendance figures not explicitly stated on the website. However, based on the hybrid format and global reach, it is anticipated to draw several hundred to over a thousand attendees, including:
- Healthcare professionals
- Researchers and academics
- Industry representatives
- Policymakers
- Students and emerging researchers
Key Focus Areas and Buyer Engagement
Key Focus Areas:
- Obesity and Metabolic Diseases
- Physical Activity, Exercise & Behavioral Therapy
- Genetics and Epigenetics of Obesity
- Childhood & Adolescent Obesity
- Obesity-Related Diseases & Health Complications
- Digital Health, Mobile Apps & AI in Obesity Management
- Diet & Nutrition
- Diabetes, Endocrinology and Obesity
- Obesity and Cardiovascular Diseases
- Bariatric Surgery: Techniques, Outcomes & Long-Term Effects
- Precision Medicine & Personalized Treatment Plans for Obesity
- Sustainable Diets & Environmental Impact of Obesity
- Non-Alcoholic Fatty Liver Disease & Liver Health
Buyer Engagement Angle: We can help you connect with key decision-makers and professionals in obesity and weight management, including researchers, healthcare providers, industry leaders, and policymakers. This event offers a unique opportunity to engage with a targeted audience involved in the latest research, treatment innovations, and policy developments in the field.
Client Product Fit Note
Please share your client's website to allow us to tailor the buyer list and engagement strategy to your specific product or service. The ideal buyers at WOC 2026 will vary based on your offering:
- If your client sells pharmaceuticals or medical devices for obesity treatment: Target pharmaceutical companies, bariatric service directors, and obesity medicine specialists.
- If your client offers digital health solutions or AI in healthcare: Focus on digital health leaders, AI in healthcare leads, and health data analytics professionals.
- If your client provides nutritional products or wellness services: Engage with directors of clinical nutrition, wellness program directors, and nutritionists.
- If your client is involved in fitness technology or exercise equipment: Connect with product managers in fitness devices, wellness program directors, and physical activity specialists.
Final Recommendation
The 6th Edition of World Obesity and Weight Management Congress (WOC 2026) is a highly relevant event for companies and organizations involved in obesity research, treatment, and management. With its global audience and hybrid format, it offers a unique platform for networking, collaboration, and showcasing products or services to a targeted and engaged audience. We recommend participating in this event to connect with key stakeholders and stay updated on the latest advancements in the field.
Industry Suggestions Based on Client Requirements
Depending on your client's specific product or service, here are some industry suggestions from the Apollo industry list:
- Health, Wellness & Fitness
- Hospital & Health Care
- Pharmaceuticals
- Medical Devices
- Digital Health & AI
- Nutrition & Food Products
- Fitness & Sports Technology
- Health Information & Media
- Professional Associations & Nonprofits
Data sheet
6th Edition of World Obesity and Weight Management Congress – Event Attendee & Buyer Profile Analysis
Event date: October 19–21, 2026
Location: Hilton Boston/Woburn, Woburn, Massachusetts, USA
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 6th Edition of World Obesity and Weight Management Congress |
| Event Date | October 19–21, 2026 |
| Event Status | Upcoming |
| Venue | Hilton Boston/Woburn |
| City | Woburn / Greater Boston |
| State / Region | Massachusetts |
| Country | United States |
| Organizer | Magnus Group |
| Official Event Website | obesityworldconference.com |
| Event Type | Hybrid conference and congress (in-person + virtual) |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; IT & Technology |
| Audience Reach | Global, supported by hybrid delivery and official positioning as an international obesity and weight management congress |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numeric attendance; high for event identity, dates, venue, format, and attendee profile based on official event website content |
| Main Purpose of Event | Scientific knowledge exchange, clinical education, research presentation, innovation showcase, collaboration building, and industry engagement in obesity and weight management |
About the Event
The 6th Edition of World Obesity and Weight Management Congress (WOC 2026) is a hybrid scientific and professional event organized by Magnus Group and scheduled for October 19–21, 2026 in the Boston, Massachusetts market, with in-person programming at Hilton Boston/Woburn and online participation for remote attendees. The official theme, “Global Perspectives on Obesity: Innovation to Impact,” positions the event around obesity research, weight management strategies, clinical practice, metabolic disease, nutrition, behavioral therapy, digital health, and related medical innovation.
From a commercial and lead-generation perspective, this is primarily a high-value B2B healthcare conference rather than a mass-consumer expo. The most relevant participants are likely to include clinicians, medical researchers, academic institutions, public health stakeholders, health-tech innovators, pharmaceutical and medical device companies, and wellness solution providers. The event matters because it combines education, speaker visibility, research dissemination, and cross-sector networking, making it potentially useful for partnership development, thought-leadership outreach, KOL engagement, and targeted account-based prospecting in obesity care and metabolic health.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Obesity medicine clinicians | Hospitals, clinics, obesity treatment centers, medical practices | Clinical evaluation, treatment adoption, referral influence | High relevance for therapies, devices, diagnostics, digital care tools, and educational services |
| Endocrinologists and metabolic disease specialists | Academic medical centers, specialty clinics, hospital systems | Influence on prescribing, protocol design, and research uptake | High-value for pharma, medical device, clinical nutrition, and evidence-based care platforms |
| Nutritionists and dietitians | Hospitals, wellness centers, private practice, public health programs | Program selection, patient education, dietary solution adoption | Relevant for nutrition products, care programs, coaching tools, meal planning technology |
| Researchers and academics | Universities, research institutes, teaching hospitals | Research partnerships, validation, trial collaboration, publication influence | Important for clinical studies, data platforms, grants, and long-term scientific credibility |
| Public health and policy stakeholders | Government agencies, public health bodies, policy organizations | Program design, guideline influence, prevention strategy adoption | Relevant for population health, prevention programs, data tools, and education initiatives |
| Pharmaceutical company teams | Drug developers, obesity therapy companies, metabolic health portfolios | Partnership evaluation, KOL engagement, scientific marketing, research collaboration | Strong relevance for therapy launches, investigator networks, and medical affairs outreach |
| Medical device and digital health leaders | Device firms, remote monitoring providers, health app companies, AI health platforms | Vendor selection, technology partnerships, integration decisions | Relevant for connected care, software, engagement tools, and metabolic monitoring solutions |
| Hospital and practice administrators | Health systems, specialty practices, integrated care networks | Budget control, procurement influence, service line development | Useful targets for care pathway solutions, staffing, software, and operational tools |
| Students and emerging researchers | Universities, postgraduate programs, teaching hospitals | Low immediate buying authority; high future influence | Best for awareness, education, and pipeline relationship building |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city / venue market | Woburn and Greater Boston | High | Boston-area hospitals, universities, biotech, medical research, and digital health companies make the local market strategically strong |
| Host state / region | Massachusetts and New England | High | Likely draw from regional academic medicine, clinical research, and specialty practices |
| Nearby business and research hubs | Cambridge, Boston, Worcester, Providence, New York corridor | Medium to High | Relevant for life sciences, digital health, public health research, and healthcare services buyers |
| National reach | United States | High | Official website positions the congress as a must-attend obesity conference in the USA, supporting national relevance |
| International reach | Global in-person and virtual attendees | Medium to High | Confirmed hybrid format and official language referencing participants from around the world support international participation |
| Virtual audience | Remote clinicians, researchers, and industry participants | Medium | Hybrid access broadens reach beyond those able to travel to Massachusetts |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The organizer explicitly promotes the event as a hybrid international congress with in-person attendance in Massachusetts and virtual participation from anywhere. |
| National | Secondary reach | Strong relevance for U.S. healthcare systems, academic institutions, and obesity care stakeholders. |
| Regional | Secondary concentration | Boston and New England likely provide a dense concentration of local medical, public health, and research participants. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Harvard Medical School | Academic medical institution | Relevant for obesity research collaboration, academic partnerships, clinical education, and thought-leadership engagement | hms.harvard.edu | Professor, Research Director, Clinical Program Director, Endocrinology Lead | Confirmed Speaker Organization |
| D & S Consulting Services Inc | Consulting / advisory organization | Relevant where advisory, healthcare strategy, or scientific consulting services intersect with obesity programs or solution deployment | Public website domain not verified from provided official event content | Principal Consultant, Healthcare Advisor, Scientific Consultant | Confirmed Speaker Organization |
| Endocrinology Metabolism Consulting, LLC | Specialist consulting practice | Relevant for endocrine and metabolic expertise connected to obesity management and clinical strategy | Public website domain not verified from provided official event content | Medical Director, Endocrinology Consultant, Clinical Advisor | Confirmed Speaker Organization |
| Hassan Heshmati and Valerie Shaw Endocrine Research | Research organization | Relevant for endocrine research, collaboration, and clinical-scientific exchange in obesity and metabolic disease | Public website domain not verified from provided official event content | Research Director, Principal Investigator, Medical Science Lead | Confirmed Speaker Organization |
Current-year organization-level participant evidence publicly visible in the provided official website content is limited. The table above includes only organizations directly named on the official page. It should not be treated as a full attendee list for the 2026 edition.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Medical Director, Obesity Medicine | Clinical | Director | Owns or influences treatment pathways, clinical program adoption, and external partnerships |
| 2 | Endocrinology Director | Clinical / Specialty Care | Director | Key decision influencer for obesity, diabetes, and metabolic disease solutions |
| 3 | Research Director | Research | Director | Important for collaborations, studies, grant programs, and scientific validation |
| 4 | Principal Investigator | Research / Clinical Trials | Senior | Influences trial participation, data generation, and product evidence development |
| 5 | Clinical Program Director | Operations / Clinical Services | Director | Can adopt patient programs, workflow tools, and multidisciplinary obesity services |
| 6 | Digital Health Director | Innovation / IT / Clinical Transformation | Director | Relevant because the program includes digital health, mobile apps, and AI in obesity management |
| 7 | Professor / Department Chair | Academic | Senior / Executive | Important for scientific credibility, partnerships, and institutional access |
| 8 | Public Health Program Manager | Public Health | Manager | Relevant for prevention, education, and population-level obesity initiatives |
| 9 | Medical Affairs Director | Medical Affairs | Director | Common pharma and device stakeholder for scientific engagement and KOL programs |
| 10 | Procurement Manager / Sourcing Lead | Procurement / Supply Chain | Manager | Relevant when selling equipment, software, services, event partnerships, or clinical support products |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core market for obesity treatment and service delivery | Clinical programs, care pathways, patient engagement tools |
| 2 | Medical Practice | Includes specialty obesity, endocrine, and nutrition clinics | Private and group practice solution sales |
| 3 | Higher Education | Academic research institutions are heavily represented | Research collaborations and institutional outreach |
| 4 | Research | Direct fit for investigators and research-focused organizations | Trial support, data platforms, publications, grant partnerships |
| 5 | Pharmaceuticals | Obesity and metabolic disease therapies are highly relevant | Medical affairs, KOL engagement, partnership targeting |
| 6 | Medical Devices | Relevant for monitoring, diagnostics, surgical and care tools | Device sales, trial programs, clinic adoption |
| 7 | Biotechnology | Supports innovation in metabolic disease and obesity science | Research partnerships and pipeline visibility |
| 8 | Health, Wellness & Fitness | Behavioral and weight management solutions align well | Coaching, prevention, digital support programs |
| 9 | Information Technology & Services | Digital health and AI sessions create clear fit | Remote care, workflow, analytics, interoperability |
| 10 | Computer Software | Relevant for obesity management apps and clinical software | Patient engagement, telehealth, care coordination |
| 11 | Government Administration | Public health policy and obesity prevention stakeholders are relevant | Program procurement, education, public health initiatives |
| 12 | Education Management | Useful for continuing education and academic program partnerships | Training, curriculum, conference partnerships |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Not confirmed | Official event website content provided | No current-year attendee count found in supplied official content |
| Exhibitor count | Not publicly confirmed | Not confirmed | Official event website content provided | This event appears conference-led rather than expo-led in the visible source content |
| Buyer count | Not publicly confirmed | Not confirmed | Official event website content provided | Healthcare and research attendees are described, but no numeric breakdown is published in the supplied text |
| Speaker / committee organizations visible | At least 4 organizations named in the provided official content excerpt | Confirmed partial evidence | Official scientific committee section excerpt | This is not a total speaker count |
| Sponsor count | Not publicly confirmed | Not confirmed | Official event website content provided | No sponsor directory was visible in the supplied text |
| Historical attendance | Not verified from provided sources | Historical / prior-year evidence unavailable in supplied text | Official website excerpt references past event pages only | No reliable historical attendance number should be inferred |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Obesity and metabolic diseases | Clinical evidence, treatment pathways, integrated care approaches | Medical education, clinical studies, program partnerships | Pharma, diagnostics, care models, clinical decision support |
| Diet and nutrition | Patient adherence, dietary planning, prevention strategies | Nutrition tools, educational partnerships, digital coaching | Clinical nutrition programs, meal planning software, evidence-based content |
| Diabetes, endocrinology and obesity | Cross-condition management and specialist collaboration | Specialist networking, treatment bundle positioning | Therapeutics, integrated monitoring, endocrine support tools |
| Physical activity, exercise and behavioral therapy | Long-term patient engagement and behavior change | Program licensing, coaching partnerships, digital behavior support | Wellness platforms, telecoaching, lifestyle intervention services |
| Bariatric surgery | Technique outcomes, long-term monitoring, referral pathways | Device and perioperative support discussions | Surgical devices, monitoring solutions, post-op support programs |
| Digital health, mobile apps and AI in obesity management | Scalable patient engagement, data capture, remote support | Live demos, pilot programs, integration conversations | Software, analytics, telehealth, AI-driven monitoring and coaching |
| Precision medicine and personalized treatment plans | Risk stratification and tailored interventions | Clinical research and personalized care positioning | Biomarkers, data platforms, decision-support, specialty diagnostics |
| Public health and prevention | Population health improvement and policy-aligned programming | Government and institutional partnerships | Education campaigns, prevention frameworks, community engagement tools |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for healthcare, research, digital health, wellness, and clinical innovation suppliers |
| Decision-maker availability | Medium to High | Direct procurement heads may be limited, but medical directors, researchers, and program leaders are likely influential buyers or specifiers |
| Data collection potential | Medium | Good for speaker and institution mapping; limited by lack of public attendee-count transparency in the supplied source |
| Apollo targeting potential | High | Healthcare, academia, pharma, devices, and digital health can be targeted effectively by industry, role, and geography |
| Geographic targeting potential | High | Boston/New England plus national and international hybrid audiences create layered targeting options |
| Best outreach approach | High | Thought-leadership email outreach, scientific relevance messaging, partnership offers, and clinical use-case positioning will outperform generic sales pitches |
| Overall lead quality | High | Best suited for specialized B2B healthcare outreach rather than broad attendee list monetization |
| Best use case | High | ABM targeting, KOL mapping, partnership development, medical affairs outreach, and research collaboration sourcing |
| Limitations / risks | Medium | Publicly visible current-year named buyer organizations are limited; event is more conference-driven than procurement-driven |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Practice; Higher Education; Research; Pharmaceuticals; Medical Devices; Biotechnology; Health, Wellness & Fitness; Information Technology & Services; Computer Software; Government Administration | Covers the most relevant buyer ecosystems around obesity management and research |
| Departments | Clinical, Research, Medical Affairs, Operations, Innovation, Information Technology, Public Health, Procurement | Captures both decision-makers and strong influencers |
| Seniority | Director, VP, Head, Chief, Partner, Professor, Owner, Manager, Senior | Targets buyers, program owners, and scientific leaders |
| Job titles | Medical Director, Director of Obesity Medicine, Endocrinologist, Research Director, Principal Investigator, Clinical Program Director, Bariatric Program Director, Digital Health Director, Medical Affairs Director, Public Health Program Manager, Nutrition Director, Procurement Manager | Precise role-level targeting aligned to likely attendees and influencers |
| Geography | Massachusetts; Greater Boston; New England; United States; selected international academic and healthcare markets | Supports local, national, and hybrid-event outreach sequences |
| Employee size | 11-50; 51-200; 201-500; 501-1000; 1001-5000; 5001+ | Includes specialist clinics through large health systems and universities |
| Keywords | obesity, weight management, bariatric, metabolic disease, endocrinology, nutrition, diabetes, lifestyle medicine, digital health, AI, remote monitoring, public health, wellness | Improves relevance beyond industry filters alone |
| Technologies, if relevant | Telehealth, patient engagement software, remote monitoring, EHR-connected applications, AI analytics | Useful for digital health and software prospecting |
| Revenue range, if relevant | Use open range; prioritize mid-market to enterprise for hospitals, pharma, devices, and universities | Balances institutional scale with practical buying capacity |
| Company type | Private, Public, Nonprofit, Educational Institution, Government | Matches the cross-sector nature of the congress |
Suggested Apollo Search Logic: ("obesity" OR "weight management" OR bariatric OR endocrinology OR "metabolic disease" OR nutrition OR diabetes OR "digital health") AND ("medical director" OR "research director" OR "program director" OR endocrinologist OR "principal investigator" OR "medical affairs director" OR "public health program manager") with geography layered as Massachusetts / Boston first, then United States, then global academic and healthcare targets.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| World Obesity and Weight Management Congress official website | Official event website | Event name, dates, hybrid format, Boston/Massachusetts/USA location, venue address, theme, attendee profile, scientific sessions, organizer identity, and named scientific committee organizations | High |
| Official website content excerpt supplied in request | Primary source text provided by user | Used as the primary source of truth for date, venue, city/region/country, hybrid status, program topics, and attendee descriptions | High |
| Verification note | Analyst note | No official attendee count, exhibitor count, sponsor list, or complete current-year attendee directory was visible in the supplied source. This report therefore distinguishes confirmed facts from likely attendee profiles and avoids unsupported attendance claims. | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Edition of World Obesity and Weight Management Congress — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds